ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2390

Color Doppler Ultrasonography an Alternative to CT/MR Angiography for Identifying Large Vessel Involvement in Giant Cell Arteritis?

Andreas P. Diamantopoulos1, Glenn Haugeberg1 and Geirmund Myklebust2, 1Rheumatology, Hospital of Southern Norway Trust, Kristiansand, Norway, 2Rheumatology, Hospital of Southern Norway, Kristiansand, Norway

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Computed tomography (CT), giant cell arteritis, magnetic resonance imaging (MRI) and ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Vasculitis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Large vessel involvement has been reported to be present in 20-50% of patients with giant cell arteritis (GCA). Computed tomography (CT) and magnetic resonance (MR) angiography are used for assessment of large vessel involvement in patients with GCA. Our aim was to compare color Doppler ultrasonography (CDUS) to CT/ MR angiography for identifying large vessel involvement in patients with GCA at the time of initial evaluation.

Methods:

Consecutive GCA patients with large vessel involvement assessed by CDUS underwent CT/MR angiography between January 2010 and May 2012. The aorta and supraaortic vessels were assessed by CT/MR angiography, while the carotid and axillary arteries were assessed by CDUS. The patients were diagnosed by CDUS with large vessel vasculitis (LVV) when intima-media complex thickness was homogenous and more than 1.5 mm in the carotid artery and more than 1 mm in the axillary artery.

Results:

A total of 13 GCA patients (7 females, 6 males, mean age 70 years) were identified with LVV using CDUS. In these 13 patients aortic involvement was observed in 5 patients (38%) by CT/MR angiography.  In all of these 5 patients, involvement of axillary arteries (4 patients) or carotid arteries (3 patients) were found by CDUS. In the other 8 patients axillary arteritis was visible on CDUS whereas only 2 these patients revealed large vessel vasculitis on CT/MR. Interestingly, inflammation in large vessels was retrospectively identified by CT/MR angiography in 6 of 13 patients and this after reevaluating the images after the positive CDUS examination.

Conclusion:

CDUS seems to be a valuable tool for assessment of large vessel vasculitis. The data from our pilot study suggest that CDUS is comparable and even better than CT/MR angiography to detect large vessel involvement in GCA. In the future CDUS may become the gold standard for first line evaluation of large vessel involvement. However further validation of the method is warranted.


Disclosure:

A. P. Diamantopoulos,
None;

G. Haugeberg,
None;

G. Myklebust,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/color-doppler-ultrasonography-an-alternative-to-ctmr-angiography-for-identifying-large-vessel-involvement-in-giant-cell-arteritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology